ArticlePloS one2021

Modeling the relative risk of SARS-CoV-2 infection to inform risk-cost-benefit analyses of activities during the SARS-CoV-2 pandemic.

John E McCarthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.